Sadra Medical

Sadra Medical is exploring new minimally invasive surgical alternatives to traditional surgical valve replacement. The company hopes that devices allowing this procedural advancement will enhance and strengthen the treatment of aortic valve disease. Sadra Medical is committed to developing new therapies for treating aortic valve disease. By developing minimally invasive alternatives to traditional surgical valve replacement methods, the company seeks to help improve patient care and make valve replacement possible for more patients. The treatment of aortic valve disease remains a significant and growing unmet clinical need. In the United States, up to 3 million people suffer from aortic stenosis; however, only a small fraction receive the current standard of treatment—valve replacement surgery using cardiopulmonary bypass in open-heart surgery. By developing a highly effective aortic valve replacement aimed at reducing the risks and morbidity associated with open surgical valve replacement, Sadra Medical seeks to provide a treatment option for patients who are currently untreated.